Swiss Cancer Institute/AbbVie Digital Innovation Award
The use of artificial intelligence and digitalization has become increasingly important in medicine and hemato-oncology. The Swiss Cancer Institute/AbbVie Digital Innovation Award, sponsored by AbbVie, supports projects that pave the way for synergies between clinical research and information technology to improve standards of care. The prize is endowed with CHF 30'000.–.
Applicants
- Practicing physicians (in a hospital or with their own practice), clinical researchers or professionals in a care facility
- Research activity mainly in Switzerland
- Funding of the project via a bank account of a healthcare facility/institution
Relevant topics, not exhaustive:
- Telemedicine
- E-patient / e-doctor
- Artificial intelligence in medicine / diagnosis / meta-analysis / big data
- apps
- Support for patient recruitment & clinical studies
- Exchange tools and formats
- E-health prevention / prediction
- Disease awareness
- Social media
- Events (congresses)
- Training and education
- Optimization of processes
- Use of blockchain technology
Application
The complete application must include the following:
- Curriculum vitae of the applicant
- Letter of support highlighting the applicant's scientific and/or clinical achievements in connection with the Swiss Cancer Institute/AbbVie Award.
- Relevant publication, manuscript or proof of concept demonstrating the feasibility and/or necessity of the project
- Publication list of the applicant, relevant to the award
Other relevant information or documents, if applicable.
Submission
Please submit your application by March 31, 2025.
Applications must be submitted electronically to the Swiss Cancer Institute, events@swisscancerinstitute.ch.
in collaboration with Abbvie